BARCLAYS PLC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 34 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$94
-3.1%
5,932
-7.9%
0.00%
Q2 2023$97
-34.9%
6,440
-37.0%
0.00%
Q1 2023$149
+2.1%
10,228
-5.1%
0.00%
Q4 2022$146
-99.2%
10,772
+786.6%
0.00%
Q3 2022$19,0001,215
+3275.0%
0.00%
Q2 2022$0
-100.0%
36
-97.9%
0.00%
Q1 2022$16,0001,7090.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders